The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase 1/2 study of anbalcabtagene autoleucel, novel anti-CD19 CAR-T cell therapy with dual silencing of PD-1 and TIGIT in relapsed or refractory large B-cell lymphoma.
 
Won Seog Kim
No Relationships to Disclose
 
Seok Jin Kim
No Relationships to Disclose
 
Sangeun Yoon
No Relationships to Disclose
 
Jong Ran Kim
Employment - ABL Bio; Curocell
Leadership - ABL Bio; Curocell
Stock and Other Ownership Interests - Curocell